Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action

Despite the significant efforts made in recent years, the latest data from the World Health Organization indicates that there are substantial challenges in achieving the elimination of hepatitis B virus (HBV) infection by 2030. The article in the <i>World Journal of Hepatology</i> by Ismael <i>et al</i> highlighted the limited accessibility to screening and antiviral treatment for HBV infection in eastern Ethiopia. Therefore, the editorial comments on this article will focus on the current challenges and recent efforts in the prevention and treatment of chronic hepatitis B, particularly emphasizing the expansion of screening and antiviral therapy, as well as feasible strategies to improve accessibility for HBV testing, antiviral therapy, and adherence enhancement.

Authors

Institutions

Publication Details

Journal
World Journal of Hepatology
Published
2024-11-05
DOI
https://doi.org/10.4254/wjh.v16.i11.1361
Primary Topic
Hepatitis B Virus Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action

Huichun Xing, Lei Ma
World Journal of Hepatology
Hepatitis B Virus Studies
article

Elimination of hepatitis B as a public health threat: Addressing the challenge and taking action

Huichun Xing, Lei Ma
article en

Abstract

Despite the significant efforts made in recent years, the latest data from the World Health Organization indicates that there are substantial challenges in achieving the elimination of hepatitis B virus (HBV) infection by 2030. The article in the <i>World Journal of Hepatology</i> by Ismael <i>et al</i> highlighted the limited accessibility to screening and antiviral treatment for HBV infection in eastern Ethiopia. Therefore, the editorial comments on this article will focus on the current challenges and recent efforts in the prevention and treatment of chronic hepatitis B, particularly emphasizing the expansion of screening and antiviral therapy, as well as feasible strategies to improve accessibility for HBV testing, antiviral therapy, and adherence enhancement.

World Journal of HepatologyVol. 16(11)
Capital Medical University (CN), Beijing Ditan Hospital (CN)
National Key Research and Development Program of China
Openalex Percentile: Top 70%
Hepatitis B Virus Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.